Edgewise Therapeutics Correlations

EWTX Stock

USD 26.26 0.46 1.72%

The current 90-days correlation between Edgewise Therapeutics and Century Therapeutics is 0.19 (i.e., Average diversification). The correlation of Edgewise Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Edgewise Therapeutics Correlation With Market

Weak diversification

The correlation between Edgewise Therapeutics and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.

Moving together with Edgewise Stock

0.88	DNLI	Denali Therapeutics	Pair Corr
0.69	DNTH	Dianthus Therapeutics	Pair Corr
0.84	DOMH	Dominari Holdings	Pair Corr
0.81	DRRX	Durect	Pair Corr
0.83	DTIL	Precision BioSciences	Pair Corr
0.85	VIGL	Vigil Neuroscience	Pair Corr
0.78	VINC	Vincerx Pharma	Pair Corr
0.86	VKTX	Viking Therapeutics	Pair Corr
0.65	VRCA	Verrica Pharmaceuticals	Pair Corr
0.84	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.76	VRPX	Virpax Pharmaceuticals	Pair Corr
0.83	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Edgewise Stock

0.83	DRTS	Alpha Tau Medical	Pair Corr
0.7	DMAC	DiaMedica Therapeutics	Pair Corr
0.7	CDIOW	Cardio Diagnostics	Pair Corr
0.66	VCEL	Vericel Corp Ord	Pair Corr
0.65	VCYT	Veracyte Potential Growth	Pair Corr
0.62	SABSW	SAB Biotherapeutics	Pair Corr
0.82	SRZNW	Surrozen Warrant	Pair Corr
0.81	VRNA	Verona Pharma PLC	Pair Corr
0.7	DYAI	Dyadic International	Pair Corr
0.68	VSTM	Verastem	Pair Corr
0.45	KTTAW	Pasithea Therapeutics	Pair Corr
0.43	DVAX	Dynavax Technologies	Pair Corr
0.42	VYNE	Vyne Therapeutics	Pair Corr
0.32	VRAX	Virax Biolabs Group	Pair Corr

Related Correlations Analysis

	IPSC	CCCC	MLYS	CGEM	TALS	ACET	VOR	IKNA	DSGN	XLO
IPSC		0.65	0.71	0.68	-0.76	0.69	-0.66	0.76	0.27	-0.28	IPSC
CCCC	0.65		0.71	0.93	-0.4	0.95	-0.59	0.62	-0.05	-0.1	CCCC
MLYS	0.71	0.71		0.79	-0.4	0.73	-0.58	0.74	0.46	-0.11	MLYS
CGEM	0.68	0.93	0.79		-0.38	0.91	-0.63	0.75	0.12	-0.1	CGEM
TALS	-0.76	-0.4	-0.4	-0.38		-0.36	0.5	-0.6	-0.15	0.25	TALS
ACET	0.69	0.95	0.73	0.91	-0.36		-0.53	0.59	-0.06	-0.17	ACET
VOR	-0.66	-0.59	-0.58	-0.63	0.5	-0.53		-0.6	-0.16	0.23	VOR
IKNA	0.76	0.62	0.74	0.75	-0.6	0.59	-0.6		0.36	-0.1	IKNA
DSGN	0.27	-0.05	0.46	0.12	-0.15	-0.06	-0.16	0.36		-0.03	DSGN
XLO	-0.28	-0.1	-0.11	-0.1	0.25	-0.17	0.23	-0.1	-0.03		XLO
	IPSC	CCCC	MLYS	CGEM	TALS	ACET	VOR	IKNA	DSGN	XLO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ACET	+ 0.95	CCCC
CGEM	+ 0.93	CCCC
ACET	+ 0.91	CGEM
CGEM	+ 0.79	MLYS
IKNA	+ 0.76	IPSC
IKNA	+ 0.75	CGEM

High negative correlations

TALS	- 0.76	IPSC
VOR	- 0.66	IPSC
VOR	- 0.63	CGEM
IKNA	- 0.6	VOR
IKNA	- 0.6	TALS
VOR	- 0.59	CCCC

Risk-Adjusted Indicators

There is a big difference between Edgewise Stock performing well and Edgewise Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Edgewise Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IPSC	3.92	(0.63)	0.00	(0.67)	0.00	0.00	6.73	(7.48)	31.00
CCCC	4.32	(0.50)	0.00	(0.26)	0.00	0.00	9.28	(8.28)	24.60
MLYS	3.37	(0.49)	0.00	(1.25)	0.00	0.00	7.79	(6.95)	26.52
CGEM	2.97	(0.64)	0.00	(2.25)	0.00	0.00	5.13	(7.10)	17.85
TALS	3.42	0.59	0.16	(0.41)	3.08	(4.19)	7.32	(5.95)	27.39
ACET	3.53	(0.55)	0.00	(0.61)	0.00	0.00	6.67	(7.89)	25.72
VOR	5.81	1.42	0.30	(9.79)	3.82	(9.36)	17.86	(6.72)	63.37
IKNA	1.48	(0.20)	0.00	(0.86)	0.00	0.00	3.87	(3.01)	16.13
DSGN	4.48	0.13	0.02	0.15	6.38	(4.64)	8.72	(11.01)	33.11
XLO	6.25	0.88	0.14	0.44	5.92	(9.53)	12.50	(11.34)	57.76

Edgewise Therapeutics Corporate Management

Badreddin Edris	CoFounder Director	Profile
John Moore	General Counsel	Profile
Behrad Derakhshan	Chief Officer	Profile
Marc MD	Chief Officer	Profile
John JD	General Counsel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC